162 related articles for article (PubMed ID: 7788255)
1. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
Madersbacher H; Stöhrer M; Richter R; Burgdörfer H; Hachen HJ; Mürtz G
Br J Urol; 1995 Apr; 75(4):452-6. PubMed ID: 7788255
[TBL] [Abstract][Full Text] [Related]
2. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
3. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
[TBL] [Abstract][Full Text] [Related]
4. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H;
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
[TBL] [Abstract][Full Text] [Related]
5. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial.
Stöhrer M; Bauer P; Giannetti BM; Richter R; Burgdörfer H; Mürtz G
Urol Int; 1991; 47(3):138-43. PubMed ID: 1771701
[TBL] [Abstract][Full Text] [Related]
6. Trospium chloride for the treatment of overactive bladder with urge incontinence.
Singh-Franco D; Machado C; Tuteja S; Zapantis A
Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial.
Cardozo L; Chapple CR; Toozs-Hobson P; Grosse-Freese M; Bulitta M; Lehmacher W; Strösser W; Ballering-Brühl B; Schäfer M
BJU Int; 2000 Apr; 85(6):659-64. PubMed ID: 10759661
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
Stöhrer M; Madersbacher H; Richter R; Wehnert J; Dreikorn K
Spinal Cord; 1999 Mar; 37(3):196-200. PubMed ID: 10213329
[TBL] [Abstract][Full Text] [Related]
9. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
Fröhlich G; Bulitta M; Strösser W
Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.
Madersbacher H; Halaska M; Voigt R; Alloussi S; Höfner K
BJU Int; 1999 Oct; 84(6):646-51. PubMed ID: 10510109
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.
Thüroff JW; Bunke B; Ebner A; Faber P; de Geeter P; Hannappel J; Heidler H; Madersbacher H; Melchior H; Schäfer W
J Urol; 1991 Apr; 145(4):813-6; discussion 816-7. PubMed ID: 2005707
[TBL] [Abstract][Full Text] [Related]
12. Trospium chloride for the treatment of detrusor instability in children.
Lopez Pereira P; Miguelez C; Caffarati J; Estornell F; Anguera A
J Urol; 2003 Nov; 170(5):1978-81. PubMed ID: 14532838
[TBL] [Abstract][Full Text] [Related]
13. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
[TBL] [Abstract][Full Text] [Related]
14. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
[TBL] [Abstract][Full Text] [Related]
15. Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia.
Höfner K; Oelke M; Machtens S; Grünewald V
World J Urol; 2001 Nov; 19(5):336-43. PubMed ID: 11760782
[TBL] [Abstract][Full Text] [Related]
16. Trospium chloride in the management of overactive bladder.
Rovner ES
Drugs; 2004; 64(21):2433-46. PubMed ID: 15482001
[TBL] [Abstract][Full Text] [Related]
17. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence.
Bödeker RH; Madersbacher H; Neumeister C; Zellner M
BMC Urol; 2010 Sep; 10():15. PubMed ID: 20840754
[TBL] [Abstract][Full Text] [Related]
19. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
[TBL] [Abstract][Full Text] [Related]
20. Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate.
Iselin CE; Schmidlin F; Borst F; Rohner S; Graber P
Br J Urol; 1997 Jun; 79(6):915-9. PubMed ID: 9202559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
